dual-target CAR T cells C-4-29
Term · Oncology and biomedicine · MLC-T-ONC-013180
A preparation of human T lymphocytes that have been genetically modified to express a dual-target CAR, with potential immunostimulating and antineoplastic activities. Upon administration, the dual-target CAR T cells C-4-29 recognize and kill tumor cells expressing the two as of yet undisclosed targets. This results in a cytotoxic T-lymphocyte (CTL) response against these tumor cells, thereby causing tumor cell lysis.
| Identifier | MLC-T-ONC-013180 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013180",
"term": "dual-target CAR T cells C-4-29",
"field": "Oncology and biomedicine",
"definition": "A preparation of human T lymphocytes that have been genetically modified to express a dual-target CAR, with potential immunostimulating and antineoplastic activities. Upon administration, the dual-target CAR T cells C-4-29 recognize and kill tumor cells expressing the two as of yet undisclosed targets. This results in a cytotoxic T-lymphocyte (CTL) response against these tumor cells, thereby causing tumor cell lysis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/dual-target-car-t-cells-c-4-29/"
}
Record 6,275 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.